Global Cord Blood Corp
Global Cord Blood Corp maintains a strong liquidity position, with a current ratio of 10.73, indicating a high ability to meet short-term obligations. The company holds CNY 6.66 billion in cash and equivalents, which is significantly higher than its total liabilities of CNY 3.66 billion, suggesting a conservative capital structure with no long-term debt. This liquidity position supports operational flexibility and reduces financial risk. In terms of profitability, the company reports a return on equity (ROE) of 10.27% and a return on assets (ROA) of 5.87%. These figures are strong and suggest efficient use of equity and assets to generate profit. The operating margin, calculated as operating income of CNY 608.87 million on revenue of CNY 1.24 billion, is approximately 49.02%, which is well above the industry median for healthcare services. The company's revenue is concentrated in a single business segment, as disclosed in its financial reporting, with no geographic diversification provided in the available data. This lack of segment and geographic diversification may expose the company to higher operational and market risks if demand in its primary market fluctuates. Looking ahead, the company is expected to maintain a stable growth trajectory, with no significant changes in revenue or earnings projected in the next fiscal year. The absence of capital expenditure and the presence of positive free cash flow of CNY 537.62 million indicate that the company is not currently investing heavily in expansion, which may limit future growth potential. The company's risk profile is characterized by low liquidity and dilution risks, with no immediate filing-based flags detected. The absence of long-term debt and the high cash reserves further support this low-risk profile. Additionally, the dilution potential is low, with no recent issuance or shelf registration activity reported. Recent filings and transcripts do not indicate any material events or strategic shifts. The company's ESG governance score of 55.9 and social score of 34.5 suggest moderate governance performance and room for improvement in social responsibility practices.
Business. Global Cord Blood Corp operates in the healthcare facilities and services industry, specializing in biotechnology, particularly in the collection, processing, and storage of cord blood for medical use.
Classification. The company is classified under the Healthcare sector, specifically in the Healthcare Services & Equipment business sector, with a confidence level of 0.92 according to verified market data.
- Global Cord Blood Corp has a strong liquidity position with a current ratio of 10.73 and no long-term debt.
- The company demonstrates high profitability with a 49.02% operating margin and ROE of 10.27%.
- Revenue is concentrated in a single business segment, with no geographic diversification disclosed.
- The company is not currently investing in expansion, as indicated by minimal capital expenditures.
- The company has a low risk profile with no immediate liquidity or dilution concerns.
- --
- # RATIONALES
- ```json
- No immediate filing-based liquidity or dilution flags were detected.